Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05319028
Title Study of Mivavotinib (CB-659) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Calithera Biosciences, Inc
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Northwestern University Evanston Illinois 60208 United States Details
Henry Ford Health Detroit Michigan 48202 United States Details
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 United States Details
Toledo Clinic Cancer Center Toledo Ohio 43623 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
The University of Texas, M. D. Anderson Cancer Center Houston Texas 77030 United States Details
The University of Texas Health Science Center at San Antonio San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from for the field